1. FC-99 reduces macrophage tenascin-C expression by upregulating miRNA-494 in arthritis.
- Author
-
Zhu, Haiyan, Fu, Juanhua, Chen, Sheng, Li, Xiaoqin, Liang, Huaping, Hou, Yayi, and Dou, Huan
- Subjects
- *
ARTHRITIS , *RHEUMATOID arthritis , *INFLAMMATORY mediators , *PATHOLOGY , *ANKLE , *LUCIFERASES - Abstract
• FC-99 inhibits the expression of tenascin-C in macrophages in arthritis mice. • FC-99 reduces tenascin-C expression by upregulating miR-494. • FC-99 relieves macrophage inflammation via the miR-494/TN-C/NF-κB pathway. • FC-99 may be a potential therapeutic candidate for treatment of rheumatoid arthritis. The excessive production of inflammatory mediators by inflammatory cells contributes to the pathogenesis of rheumatoid arthritis. Tenascin-C (TN-C) is expressed in rheumatoid joint, and is associated with levels of inflammatory mediators. FC-99 (N1-[(4-methoxy)methyl]-4-methyl-1,2-Benzenediamine), a novel 1,2-benzenediamine derivative, was previously reported to block the prolonged expression of key rheumatoid arthritis inflammatory cytokines and relieve zymosan-induced joint inflammation. However, the specific mechanism is unknown. This study aimed to examine the effects of FC-99 on TN-C expression and inflammation and investigate its possible molecular mechanism. The results showed that FC-99 treatment reduced the high expression of TN-C in ankle joints of arthritis mice. Besides, FC-99 reduced the increased number of macrophages in arthritis mice, while did not change the number of synovioblasts. Concomitantly, expression of TN-C in synovial fibroblasts exhibited no difference between control and ZIA groups, and was not apparently altered following FC-99 treatment, while FC-99 decreased TN-C expression in macrophages both in vivo and in vitro. Meanwhile, TargetScan and luciferase assays indicated that TN-C was negatively regulated by miR-494. Transfection assay further demonstrated that FC-99 inhibited TN-C by targeting miR-494. Furthermore, the reduction of miR-494 mimic on expression of TN-C was associated with NF-κB pathway. Similarly, the down-regulation of FC-99 on TN-C was considerably decreased when NF-κB pathway was inhibited. These results indicated that FC-99 relieved macrophages inflammation via the miR-494/TN-C/NF-κB pathway, finally leading to the relief of inflammation in arthritis. The findings suggested that FC-99 might be a potential therapeutic candidate for the treatment of rheumatoid arthritis. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF